Skip to main content

Table 1 Literatures review of clinical characteristics of mucinous cystic neoplasm during pregnancy

From: Mucinous cystic neoplasm of the pancreas activated during pregnancy

Author [reference number]

Age

Maximum diameter of tumor (cm)

Diameter of tumor growth during pregnancy (mm)

CA19-9 (U/mL)

Timing of operation

Histological diagnosis

ER/PgR

Prognosis (years)

Smithers [6]

33

10

NA

NA

During pregnancy

Adenocarcinoma

NA

NA

Baiocchi [7]

29

NA

NA

NA

After delivery

Adenocarcinoma

NA

Alive (2)

Olsen [8]

25

5

0

NA

During pregnancy

Benign

NA

 

Ganepola [9]

37

12

65

NA

During pregnancy

Benign

+/+

 

Kato [10]

33

22

+

NA

During pregnancy

Benign

+/+

 

Matsunaga [11]

28

20

+

NA

During pregnancy

Adenocarcinoma

−/+

NA

Fernandez [12]

26

15

NA

NA

During pregnancy

Benign

NA

 

Herring [13]

34

20

80

NA

During pregnancy

Adenocarcinoma

+/+

Alive (NA)

Ozden [14]

32

15

NA

NA

After delivery (emergency cesarean)

Adenocarcinoma

−/−

Alive (1)

Ishikawa [15]

33

18

60

NA

After delivery

Benign

−/−

 

Ikuta [16]

30

18

NA

Normal

After delivery (abortion)

Benign

+/+

 

Hakamada [17]

38

14

40

NA

During pregnancy

Benign

NA/+

 

Wiseman [18]

32

15

NA

NA

During pregnancy

Benign

+/+

 

Brown [19]

38

10

NA

NA

During pregnancy

Benign

NA

 

Shirakawa [20]

34

19

0

Elevated

After delivery

Benign

+/+

 

Asciutti [21]

31

8

65

214

After delivery

Benign

NA

 

Nagamura [22]

32

11

NA

4,750

After delivery (emergency cesarean)

Adenocarcinoma

−/+

Alive (3)

Boyd CA [23]

21

17.2

0

NA

During pregnancy

Benign

NA

 

Tsuda [24]

28

14

10

10

During pregnancy

Benign

+/+

 

Present case

33

7.6

16

2,157

After delivery

Benign

+/+

 
  1. CA19-9, cancer antigen 19–9; ER, estrogen receptor; NA, not available; PgR, progesterone receptor.